Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00555048 · OUTCOME

Lowest Dose of Alemtuzumab Associated With Transplant-related Mortality

Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer · Source last updated 2017-05-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
mg total dose
Interval / dispersion
Not reported
Time frame
Up to day 180

What was measured

Lowest dose of alemtuzumab associated with transplant-related mortality at day 180

Groups in this outcome

Alemtuzumab

Alemtuzumab given together with busulfan and cyclophosphamide followed by a donor stem cell transplant. alemtuzumab busulfan cyclophosphamide methotrexate tacrolimus allogeneic hematopoietic stem cell transplantation peripheral blood stem cell transplantation

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Alemtuzumab1

Reported measurements

Source class 1
Values in mg total dose · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Alemtuzumab40Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        40
denoms
  1. counts
    1. group Id
      OG000
      value
      1
    units
    Participants
description
Lowest dose of alemtuzumab associated with transplant-related mortality at day 180
groups
  1. description
    Alemtuzumab given together with busulfan and cyclophosphamide followed by a donor stem cell transplant. alemtuzumab busulfan cyclophosphamide methotrexate tacrolimus allogeneic hematopoietic stem cell transplantation peripheral blood stem cell transplantation
    id
    OG000
    title
    Alemtuzumab
param Type
NUMBER
reporting Status
POSTED
time Frame
Up to day 180
title
Lowest Dose of Alemtuzumab Associated With Transplant-related Mortality
type
PRIMARY
unit Of Measure
mg total dose

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice